Serum Institute of India to produce vaccines with Nigeria

Published On 2022-09-15 10:30 GMT   |   Update On 2022-09-15 10:30 GMT

Nigeria: Nigeria will partner with Serum Institute of India to start local manufacturing of vaccines used in the country's immunisation programmes, health minister Osagie Ehanire said on Wednesday.Africa's most populous country imports all of its vaccines, including those used to prevent polio, measles and tuberculosis, but has been seeking foreign partners to produce them at home."We hope...

Login or Register to read the full article

Nigeria: Nigeria will partner with Serum Institute of India to start local manufacturing of vaccines used in the country's immunisation programmes, health minister Osagie Ehanire said on Wednesday.

Africa's most populous country imports all of its vaccines, including those used to prevent polio, measles and tuberculosis, but has been seeking foreign partners to produce them at home.

"We hope to start manufacturing some of the vaccines (that) Serum Institute India manufactures and transfer the technology and skills to our people," Ehanire said after Nigeria's cabinet approved the deal with Serum Institute, the world's largest producer of vaccines.

Read also: Serum Institute gets CDSCO Panel nod to manufacture Tdap vaccine for 4-55 year age group

"We are talking first of all the routine vaccines, the ones (for) the standard programme on immunisation, not COVID-19 vaccine."

Ehanire said the venture between Bio Vaccine Nigeria and Serum Institute would start by producing 15% of vaccines used in local immunisation. The government owns a 49% stake in Bio Vaccine and private investors control the rest.

Read also: SII, Novavax report full product registration in South Africa of COVID jab NVX-CoV2373 for adults aged 18 and older

Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News